Epica International’s mobile imaging platform gains FDA approval
Epica International, a San Clemente, California-based medical imaging technology company, has received FDA clearance for its multi-modality mobile imaging platform.
The platform, SeeFactorCT3, can be used to obtain CT scans, fluoroscopy and digital x-rays. It also includes a detachable patient table/chair and drape for interventional procedures. It was designed to be used by physicians, technologists, surgeons and dentists for a variety of procedures.
“I am very pleased to announce this major milestone event in Epica’s history, our progression into the human medical space,” Frank D. D’Amelio, CEO of Epica International, said in a prepared statement.
In the same statement, Epica promoted the ongoing development of its Medical Robot prototypes, which “will allow physicians to visualize target anatomy, plan surgical intervention and then execute the procedure wit the surgeon’s preferred instruments.”
Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.